pentobarbital will decrease the level or effect of isradipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Not known.
pentobarbital will lower the extent or influence of tipranavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
pentobarbital decreases amounts of ponatinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Steer clear of unless the coadministration outweighs the doable hazard of ponatinib underexposure; keep an eye on for indications of reduced efficacy.
Medication that call for prior authorization. This restriction calls for that specific clinical requirements be satisfied prior to the approval from the prescription.
With therapeutic doses of TCAs, barbiturates raise metabolism and decrease blood concentrations of TCAs.
pentobarbital will reduce the extent or effect of naloxegol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Usage of naloxegol with sturdy CYP3A4 inducers will not be advised
pentobarbital will reduce the extent or influence of estrogens esterified by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
If inducer is discontinued, consider oliceridine dosage reduction and keep an eye on for signs of respiratory depression.
pentobarbital increases levels of vortioxetine by rising metabolism. Modify Therapy/Keep an eye on Closely. Consider raising the vortioxetine dose when coadministered with solid CYP inducers for >14 days; not to exceed three instances unique vortioxetine dose.
pentobarbital will lessen the level or effect of darunavir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
pentobarbital will reduce the extent or influence of tolterodine by affecting hepatic/intestinal enzyme you can try these out CYP3A4 metabolism. Use Warning/Keep an eye on.
Contraindicated (1)pentobarbital will lower the level or effect of lumacaftor/ivacaftor by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lessen the extent or influence of abemaciclib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Coadministration of abemaciclib with strong CYP3A4 inducers cuts down plasma concentration of abemaciclib and its metabolites.
benzhydrocodone/acetaminophen and pentobarbital both of those improve sedation. Avoid or Use Alternate Drug. Limit use to sufferers for whom alternative remedy possibilities are insufficient